2016 (v1)
Publication
No description
Uploaded on: April 14, 2023
-
-
2016 (v1)Publication
BACKGROUND:Female carriers of Duchenne muscular dystrophy (DMD), although usually asymptomatic, developmuscle weakness up to 17% of the time, and a third present cardiac abnormalities or cognitive impairment. Clinicalfeatures of DMD carriers during childhood are poorly known.PATIENTS:We describe a cohort of pediatric DMDcarriers, providing...
Uploaded on: April 14, 2023 -
2015 (v1)Publication
No description
Uploaded on: October 11, 2023 -
2016 (v1)Publication
Activation of the proteasome pathway is one of the secondary processes of cell damage, which ultimately lead to muscle degeneration and necrosis in Duchenne muscular dystrophy (DMD). In mdx mice, the proteasome inhibitor bortezomib up-regulates the membrane expression of members of the dystrophin complex and reduces the inflammatory reaction....
Uploaded on: April 14, 2023